**Young Father’s Battle Against Terminal Cancer Takes Hopeful Turn**
:max_bytes(150000):strip_icc():format(jpeg)/Spencer-Laird-031826-03edb6c2377847eba25ba1ab762636bf.jpg)
At the age of just 26, Spencer Laird faced a life-altering battle when he was diagnosed with colon cancer. Following an aggressive surgical procedure that involved the removal of 16 inches of his colon, Laird believed he had conquered the disease. After two years of treatment and check-ups, he returned to his regular life, relishing moments with his wife CarleyAnn and their young daughter. However, the relief was short-lived.
In December 2024, a routine follow-up appointment led to unexpected news. CarleyAnn, concerned about her husband’s unusual fatigue, persuaded their doctor to conduct a full-body scan. The results were shocking — the cancer had returned and metastasised to Laird’s lungs. Medical assessments revealed a total of 13 tumours, one of which was as large as a golf ball. Faced with such dire circumstances, Spencer’s doctor estimated he had a mere two years to live.
Spencer vividly recalls the flood of emotions in that moment, stating, “So much went through my head. I just thought: I’m 30 years old. I’ve got a wife. I’ve got a 5-year-old little girl. There was the shock of it.” His wife, CarleyAnn, echoed his sentiment, sharing how she spent sleepless nights contemplating the possibility of losing her husband and having to break such heartbreaking news to their daughter.
In an effort to seek new avenues of treatment, CarleyAnn diligently applied for various clinical trials, eventually finding an opening in a study by Dr. Nicholas DeVito, a gastrointestinal oncologist at Duke Cancer Centre. Immunotherapy is typically reserved for patients who have exhausted other treatment options, but Spencer’s situation warranted exploration of this innovative approach. Dr. DeVito noted that this treatment is considered a “fourth or fifth line of defence,” with roughly a 25% success rate.
Spencer, faced with the stark reality of his prognosis, decided to participate in the clinical trial in February 2025. He became one of 15 patients to receive immunotherapy infusions every few weeks. Remarkably, the treatment showed promising results, with Spencer’s tumours shrinking from 13 to just three. “It’s a miracle. It’s really a miracle from God,” he commented, reflecting on the transformative impact of the treatment.
In the spring of 2025, as Spencer’s side effects began to dissipate, CarleyAnn reported that their life had become “smooth sailing” once again. The couple’s optimism grew as they learned from Dr. DeVito that they were entering new territory. “This diagnosis would probably have shortened his life to five years or less, at best,” the oncologist stated. “And now we’re thinking, ‘Well, is he cured? How long does this remission last? Is it permanent?’ We’re really drifting into uncharted territory.”
Though Spencer has not yet achieved complete remission, his current health status has dramatically improved, and he no longer bears a terminal diagnosis. His experience has imparted a vital lesson about the value of life and the importance of cherishing each day. “It really just taught me to try to live life,” he remarked. “There’s no sense sitting around being lazy. If the good Lord wakes you up every day and you got breath in your lungs, just go do something.”
The Laird family’s journey through cancer has not only illuminated the potential of immunotherapy but also emphasised the resilience of the human spirit in the face of adversity. As they continue to navigate this uncertain path, their story resonates with hope, underscoring the importance of remaining proactive in the fight against cancer while cherishing every precious moment together. Spencer’s tale serves as a reminder that even in the darkest times, unexpected turns can lead to newfound hope and possibility.